February 28, 2009

ADHD Drugs Induce Hallucinations in Kids–FDA safety Officers

The review included 49 randomized, controlled clinical trials in the pediatric development programs, as well as postmarketing

Read More
ADHD Drugs Induce Hallucinations in Kids–FDA safety Officers

November 30, 2007

Letter of Complaint to FDA Commissioner, 2007

                                 ALLIANCE FOR HUMAN RESEARCH PROTECTION   www.ahrp.org 142 West End Avenue, Suite 28P New York, NY

Read More
Letter of Complaint to FDA Commissioner, 2007

February 20, 2007

“Real Men, Real Depression” Marketing Masquerading as Medical News_Newsweek

Newsweek’s featured article: “Men and Depression: New Treatments” (February 26, 2007) s is an infomercial masquerading as

Read More
“Real Men, Real Depression” Marketing Masquerading as Medical News_Newsweek

February 19, 2007

Real Men, Real Depression—-Marketing Masquerading as Medical News_Newsweek

“Real Men, Real Depression campaign <http://menanddepression.nimh.nih.gov/infopage.asp?ID=1> ”–in Newsweek: “Men and Depression: New Treatments” (February 26, 2007). This

Read More
Real Men, Real Depression—-Marketing Masquerading as Medical News_Newsweek

January 6, 2007

Lilly -Zyprexa Casualties-$1.2 Billion Settlements-More Casualties_NYT_WSJ

The latest Eli Lilly- Zyprexa settlement for another massive lawsuit brought by 18,000 people who claimed they

Read More
Lilly -Zyprexa Casualties-$1.2 Billion Settlements-More Casualties_NYT_WSJ

December 18, 2006

Company Documents Show Eli Lilly Promoted Zyprexa for Unapproved Use_NYT

Federal law prohibits drug companies from promoting drugs for uses unapproved by the FDA. Zyprexa (olanzapine) is

Read More
Company Documents Show Eli Lilly Promoted Zyprexa for Unapproved Use_NYT

December 17, 2006

DRUG FILES SHOW LILLY PROMOTED ZYPREXA FOR UNAPPROVED USE

THE NEW YORK TIMES DRUG FILES SHOW MAKER PROMOTED UNAPPROVED USE December 18, 2006 By ALEX BERENSON

Read More
DRUG FILES SHOW LILLY PROMOTED ZYPREXA FOR UNAPPROVED USE

December 5, 2006

Assaultive Prescribing of Psych Drugs for Children

Suffer the little children for the drug companies and their duly financially awarded physicians, patient “advocacy” groups

Read More
Assaultive Prescribing of Psych Drugs for Children

December 1, 2006

New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost

The second phase of the government study, Clinical Antipsychotic Trials inIntervention Effectiveness (CATIE), was released and the

Read More
New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost

November 9, 2006

Psychiatrist Challenges Ethics of Yale Drug Experiment

Ethical research on the use of medicines must carefully consider whether human test subjects are being exposed

Read More
Psychiatrist Challenges Ethics of Yale Drug Experiment

October 26, 2006

FDA Warning Letter: child died from overdose during clinical trial

FDA Warning Letter: child died from overdose during clinical trial Monday, May 05, 2003 The FDA’s letter

Read More
FDA Warning Letter: child died from overdose during clinical trial

October 26, 2006

Lilly to Add Suicide Warning to Strattera – Medicaid May shrink $5.5 Billion spending on Schizophrenia Drug

Lilly to Add Suicide Warning to Strattera – Medicaid May shrink $5.5 Billion spending on Schizophrenia Drug

Read More
Lilly to Add Suicide Warning to Strattera – Medicaid May shrink $5.5 Billion spending on Schizophrenia Drug

October 26, 2006

"Schizophrenia Digest" Canadian magazine

“Schizophrenia Digest” Canadian magazine Tue, 3 Jun 2003 Behold the new marketing promo in the guise of

Read More
"Schizophrenia Digest" Canadian magazine

October 26, 2006

AMA Serves Pharma Marketing Priority/ FDA To Add Warnings on ADHD drugs–Concerta, Ritalin, Strattera, Adderall

AMA Serves Pharma Marketing Priority/ FDA To Add Warnings on ADHD drugs–Concerta, Ritalin, Strattera, Adderall Wed, 29

Read More
AMA Serves Pharma Marketing Priority/ FDA To Add Warnings on ADHD drugs–Concerta, Ritalin, Strattera, Adderall